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Delirium is associated with circadian rhythm disruption. In this study we have explored whether cir-
cadian variation of melatonin is an indicator for delirium. Melatonin levels were determined from the
ﬁrst day of hospitalization and up to three days after the onset of delirium. Patients who did not de-
veloped delirium exhibited a daily melatonin rhythm, while in patients that developed delirium, the
melatonin rhythm was lost and mean melatonin levels were found decreased as early as three days
before the diagnosis of delirium, indicating that on arrival to the hospital circadian melatonin disruption
can be used as an indicator of delirium.
& 2016 Brazilian Association of Sleep. Production and Hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Delirium is a neuropsychiatric syndrome characterized by a
ﬂuctuating mental and behavioral condition. It can include re-
duced alertness, global cognitive decline, delusional-hallucinatory
phenomena, mood swings and gross disturbances of behavior [1].
Delirium has a higher prevalence among older patients, with a
proportion of 11–42% [2]. Symptoms of delirium are tightly related
with circadian rhythm and sleep disruption. In patients developing
delirium, the sleep/wake cycle is reversed and patients are drowsy
and take naps during the day, while nighttime sleep is short and
fragmented [3]. Overall, 73% of delirious patients have at least
moderate alterations of sleep/wake cycle [4]; while in older pa-
tients these alterations reach up to 98% [5].
The integrity of the sleep/wake cycle and the temporal order
for a variety of physiological and behavioral functions, including
melatonin, are driven by the circadian system. The synthesis and
release of melatonin is dependent on the adequate internal syn-
chronization between the suprachiasmatic nuclei and the pineal
gland. Moreover, as melatonin receptors are present induction and Hosting by Elsevier B.
sidad Nacional Autónoma de
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nucleus, the reproductive system, renal and immune systems,
among others [6,7], melatonin is suggested to function as an in-
ternal signal of circadian synchronization [8,9]. This feature points
out the relevance of studying melatonin as a reliable indicator of
the timing in the circadian system.
Several studies have suggested that delirium is accompanied by
a loss of temporal variation in plasma melatonin. In patients that
underwent major abdominal surgery and developed postoperative
delirium, plasma levels of melatonin were reduced and suffered
sleep disturbances, including delayed sleep phase disorder or re-
versal of the sleep-wake cycle [10]. A different study reported
cases of delirium in ICUs that presented a loss of melatonin cir-
cadian rhythms [11]. Other indicators of melatonin secretion are
also altered in delirious patients, like urinary levels of the meta-
bolite of melatonin; 6-sulphatoxymelatonin (6-SMT), which are
mainly elevated in hypoactive patients and decreased in hyper-
active patients [12].
In order to further determine whether the loss of melatonin
rhythmicity can be used as an indicator for the onset of delirium,
patients' melatonin levels were assessed from their ﬁrst day of
hospital admission up to delirium onset or until hospital dis-
charge. Data reported here indicate that melatonin levels are
modiﬁed before delirium onset and that the loss of melatonin
rhythms can be used as a strategy to predict risk to developV. This is an open access article under the CC BY-NC-ND license
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prognosis.2. Subjects and methods
This study was conducted in the inpatient service of the De-
partment of Internal Medicine at general hospital “Dr. Manuel Gea
González” in Mexico City. All patients (465 years) admitted be-
tween 2012 December to 2013 February who signed informed
consent forms were included; patients who were taking drugs that
entrain circadian rhythms were excluded. All participants under-
went a daily evaluation of delirium risk based on the DSM-IV-TR
diagnostic criteria, and provided daytime and nighttime melatonin
samples. Due to budget constraints, two investigators that were
trained for the collection of samples of salivary melatonin and
diagnosis of delirium and blinded to the patients' condition, ana-
lyzed the samples of 7 patients who developed delirium (D), from
3 days prior to 3 days after its setting. The mean day of delirium
onset in these patients was the fourth day of hospitalization,
therefore, 6 patients who didn't develop delirium (ND) until dis-
charges were randomly selected, and their melatonin levels ana-
lyzed from days 1 through 7 of hospitalization. The study was
approved by the ethical committee of the “Dr. Manuel Gea Gon-
zález” Hospital; No.14-82-2012. Patients received their food at
8:00 and 19:00 h.
2.1. Lighting conditions
Lighting conditions in the Internal Medicine service was
131717.8 lx, during the day with light provided by overhead
ﬂuorescent white lamps from 07:00 to 19:00, and of 40.38711 lx
during the night (19:00 – 07:00).
2.2. Melatonin determination
In all patients, saliva samples were obtained in the morning
(07:00 h) and at night (21:00 h), from the day of admission until
hospital discharge. Salivary samples were taken by suction in the
oral cavity and stored under refrigeration, until analysis. Con-
centration of salivary melatonin was determined with a kit for
ELISA method (enzyme immunoassay for direct quantitative de-
termination of melatonin in human saliva; of IBL International; No.
Cat. RE54041).
2.3. Statistical analysis
The age difference between groups was compared using in-
dependent samples T-test. The melatonin concentration, was
classiﬁed as repeated measures and was compared using a two-
way analysis of variance (ANOVA), followed by a Tukey post hoc
test with signiﬁcant values set at Po0.05. Statistical analysis wasTable 1
Clinical characteristic of patients at admission.
Groups and patients Age
Control Delirium Control Delirium
1 1 66 85
2 2 71 76
3 3 72 82
4 4 70 69
5 5 82 81
6 6 71 78
7 70
N¼6 N¼7 7272.22 77.2872.32performed with the program STATISTICA version 4.5 and graphs
were elaborated with Sigma Plot version 12.3. Results
The mean age for the ND group was 7275.32, and 78.575.61
for the D group; there was no statistical difference between them
(p¼0.696). The underlying disease, for which the patients were
admitted to the hospital did not inﬂuence the difference in the
results since admission diagnoses were counterbalanced (Table 1).
In ND patients (n¼6), saliva melatonin exhibited low levels in the
day and high levels in the night, resulting in a daily rhythm in
melatonin concentration (see Fig. 1A). The ANOVA indicated sta-
tistical differences between light and dark phases (F (1,10)¼174.48;
po0.0001). In the delirium group, melatonin levels remained low
in the morning and in the evening, thus resulting in no daily
rhythm. Analyzing the seven days (the day of onset of delirium,
three days before and three days after), the ANOVA did not show
statistical differences between the day and night values
(F(1,12)¼1.051; p¼N.S; see Fig. 1A).
In patients that developed delirium, melatonin levels turned
out constant three days before the diagnosis of deliriumwas given,
while melatonin levels in the ND remained rhythmic even three
days prior to discharge. The ANOVA indicated signiﬁcant differ-
ences between groups (F(1,66)¼48.90; po0.00001), due to the
factor time (F(5,66)¼8.977; po0.0001), and in the interaction of
groups X time (F (5,66)¼17.447; po0.00001) (see Fig. 1B).
Finally, we observed that melatonin levels in the group of pa-
tients with delirium, show a loss of rhythmicity after and before of
delirium (Fig. 1C).4. Discussion
Delirium is a common syndrome that increases morbidity and
mortality in the hospitalized population, which can be a frigh-
tening and distressing experience for patients, their families and
caregivers [13]. The need for early diagnosis is crucial to improve
the prognosis of the sufferer. This study suggests that there is a
relationship between the syndrome of delirium and melatonin
daily rhythms. This relationship was previously demonstrated in a
group of patients who developed delirium syndrome after alcohol
withdrawal [14]. The incidence of delirium is also related to the
photoperiod, with a higher incidence of delirium in winter when
days are short and melatonin production is increased [15]. This
relationship was also previously reported by Wahlund et al. [16],
who found that melatonin levels were associated with the level of
psychomotor activity in subtypes of affective disorders.
The sleep-wake cycle and psychomotor activity are both under
signiﬁcant circadian regulation and appear to be disturbed in pa-
tients developing delirium, suggesting that the integrity of theDiagnosis on admission
Control Delirium
Scleroderma Sacral decubitus ulcer
Metabolic syndrome Type 2 diabetes
Heart failure, cirrhosis hepatic Hart failure
Heart failure and hypertension Heart failure and hypertension
Metabolic syndrome Metabolic syndrome
Acute kidney injury Acute kidney injury
Gastrointestinal hemorrhage
Fig. 1. A) Levels of salivary melatonin during the day and night, in the ND and D. B)
Circadian pattern of the three days prior to hospital discharge in ND group and
three days before the onset of delirium in the D group. C) Daily pattern of mela-
tonin levels in the group of patients who developed delirium and ND for 7 con-
secutive days. Values are Means7SE. (*) Signiﬁcant Difference between ND and D;
Po0.05; (þ) Signiﬁcant difference between Day and night; Po0.05.
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lirium [17]. Moreover there is evidence that exogenous melatonin
at low doses administered every night to elderly patients admitted
to intensive care may be a potential protective agent against the
development of delirium [18]. However, once an initial episode ofdelirium is registered, melatonin does not reduce the severity of
delirium, duration of hospital stay, the restraint or sedative use, or
mortality [18,19], which further supports the preventive role of
melatonin administration in the environment clinic [19] and in the
surgical setting [20].
Delirium is a syndrome that requires an early diagnosis to
improve patients' prognosis [21]. This study suggests a possible
relationship between delirium and loss of melatonin rhythmicity.
The limitations of our study are the reduced sample size, and lack
of control for other variables besides age.5. Conclusions
There is a close relationship between the disruption of the
circadian system and the development of delirium. Such ﬁndings
together with present data indicate a strong association between
melatonin daily rhythms and delirium onset thus determining
melatonin daily rhythm may be a useful predictive strategy for
developing delirium. This strategy is not invasive and does not
interfere with the general condition of the patient.Conﬂict of interest
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